The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH MM 2018 | Real world evidence: what is it and what can it tell us?
The importance of real world data is becoming increasingly apparent. Here, Kwee Yong, PhD, FRCP, FRCPath, from University College London, London, UK, discusses real world evidence and the many reasons why it is essential, in addition to clinical trial data. This interview was recorded at the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France.
